Campath

In the US, Campath (alemtuzumab systemic) is a member of the drug class CD52 monoclonal antibodies and is used to treat Chronic Lymphocytic Leukemia and Rheumatoid Arthritis.

US matches:

• Campath

Ingredient matches for Campath

Alemtuzumab

Alemtuzumab is reported as an ingredient of Campath in the following countries:

• Argentina


• Peru


• Russian Federation


• United States

International Drug Name Search